Caspofungin-mediated β-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae

Journal of Infectious Diseases

Volumn 198, Issue 2, 2008, Pages 186-192

  Lamaris, Gregory A ^a   Lewis, Russell E ^a,b   Chamilos, Georgios ^a   May, Gregory S ^a   Safdar, Amar ^a   Walsh, Thomas J ^c   Raad, Issam I ^a   Kontoyiannis, Dimitrios P ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; BETA GLUCAN; BETA GLUCAN MONOCLONAL ANTIBODY; CASPOFUNGIN; DECTIN 1; ECHINOCANDIN; MICAFUNGIN; MONOCLONAL ANTIBODY; TETRAZOLIUM;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FUNGUS HYPHAE; FUNGUS ISOLATION; FUSARIUM OXYSPORUM; FUSARIUM SOLANI; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IN VITRO STUDY; INCUBATION TIME; NEUTROPHIL; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHIZOPUS ORYZAE; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; BETA-GLUCANS; CELL WALL; ECHINOCANDINS; FUSARIUM; HUMANS; HYPHAE; MADUROMYCOSIS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHIZOPUS; SCEDOSPORIUM; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 47649090076     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/589305     Document Type: Article

References (37)

1. Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005; 56:i5-11.
2. Singh N. Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients. Lancet Infect Dis 2003; 3:156-61.
3. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis 2002; 21:161-72.
4. Cappelletty D, Eiselstein-McKitrick K. The echinocandins. Pharmacotherapy 2007; 27:369-88.
5. Pfaller MA, Marco F, Messer SA, Jones RN. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis 1998; 30:251-5.
6. Ibrahim AS, Bowman JC, Avanessian V, et al. Caspofungin inhibits Rhizopus oryzae 1,3-β-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother 2005; 49:721-7.
7. Nivoix Y, Zamfir A, Lutun P, et al. Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections. J Infect 2006; 52:67-74.
8. Ostrosky-Zeichner L, Paetznick VL, Rodriguez J, Chen E, Kartsonis NA, Douglas C. Activity of caspofungin alone and in combination with amphotericin B lipid complex (ABLC) in a murine model of fusariosis (poster M-1841/482). In: Proceedings of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 2007:457.
9. Kahn JN, Hsu MJ, Racine F, Giacobbe R, Motyl M. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of β-D-1,3 glucan levels in culture. Antimicrob Agents Chemother. 2006; 50:2214-6.
10. Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 2006; 6:33-43.
11. Brown GD, Gordon S. Immune recognition of fungal β-glucans. Cell Microbiol 2005; 7:471-9.
12. Brown GD, Gordon S. Immune recognition: a new receptor for β-glucans. Nature 2001; 413:36-7.
13. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. Dectin-1 mediates the biological effects of β-glucans. J Exp Med 2003; 197:1119-24.
14. Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4:1-23.
15. Wheeler RT, Fink GR. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog 2006; 2:e35.
16. Gersuk GM, Underhill DM, Zhu L, Marr KA. Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol 2006; 176:3717-24.
17. Hohl TM, Van Epps HL, Rivera A, et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific β-glucan display. PLoS Pathog 2005; 1:e30.
18. Shedletzky E, Unger C, Delmer DP. A microtitre-based fluorescence assay for (1,3)-β-glucan synthases. Anal Biochem 1997; 249:88-93.
19. Bowman JC, Hicks PS, Kurtz MB, et al. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob Agents Chemother 2002; 46:3001-12.
20. Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ. Interferon-γ and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important Zygomycetes. J Infect Dis 2005; 191:1180-7.
21. Meshulam T, Levitz SM, Christin L, Diamond RD. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2- methoxy-4-nitro-5-sulphenyl)-(2 H)-tetrazolium-5-carboxanilide (XTT). J Infect Dis 1995; 172:1153-6.
22. Bellocchio S, Moretti S, Perruccio K, et al. TLRs govern neutrophil activity in aspergillosis. J Immunol 2004; 173:7406 -15.
23. Denning DW. Echinocandin antifungal drugs. Lancet 2003; 362:1142-51.
24. Angiolella L, Maras B, Stringaro AR, et al. Glucan-associated protein modulations and ultrastructural changes of the cell wall in Candida albicans treated with micafungin, a water-soluble, lipopeptide antimycotic. J Chemother 2005; 17:409-16.
25. Hohl TM, Feldmesser M, Perlin DS, Pamer EG. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal β-glucan exposure [abstract 182]. In: Program and abstracts of the 45th Annual Meeting of the Infectious Diseases Society of America. Arlington, VA: Infectious Diseases Society of America, 2007.
26. Choi JH, Brummer E, Stevens DA. Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus. Microbes Infect 2004; 6:383-9.
27. Chiller T, Farrokhshad K, Brummer E, Stevens DA. The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity against Aspergillus fumigatus. Diagn Microbiol Infect Dis 2001; 39:99-103.
28. Ishibashi K, Yoshida M, Nakabayashi I, et al. Role of anti-β-glucan antibody in host defense against fungi. FEMS Immunol Med Microbiol 2005; 44:99-109.
29. Herre J, Willment JA, Gordon S, Brown GD. The role of Dectin-1 in antifungal immunity. Crit Rev Immunol 2004; 24:193-203.
30. Ha YS, Covert SF, Momany M. FsFKS1, the 1,3-β-glucan synthase from the caspofungin-resistant fungus Fusarium solani. Eukaryot Cell 2006; 5:1036-42.
31. Steele C, Marrero L, Swain S, et al. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 β-glucan receptor. J Exp Med 2003; 198:1677-88.
32. Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 2005; 24:1277-86.
33. Viriyakosol S, Fierer J, Brown GD, Kirkland TN. Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1. Infect Immun 2005; 73:1553-60.
34. Bochud PY, Chien JW, Janer M, Marr KA, Aderem A, Boeckh M. Donor's Toll-like receptor (TLR) 4 haplotypes increase the incidence of invasive mold infections in hematopoietic stem cell transplant recipients [abstract B-1329]. In: Program and abstracts of the 46th Interscience Congress on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 2006: 54.
35. Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem 2003; 278:37561-8.
36. Lewis RE, Chamilos G, Prince RA, Kontoyiannis DP. Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice. Antimicrob Agents Chemother 2007; 51:1078-81.
37. Kurtz MB, Heath IB, Marrinan J, Dreikorn S, Onishi J, Douglas C. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrob Agents Chemother 1994; 38:1480-9.